Autolus announces changes to its Board and Management Team
04 août 2020 07h00 HE
|
Autolus Therapeutics plc
LONDON, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...